![]() Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | ||
Founding Date | Founding Date 2010 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Los Angeles, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees 27214% decrease | Employees 80 |
Valuation ($) | Valuation ($) 136.8 m | Valuation ($) 42.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) kr71.1m (FY, 2025) |
Cost of goods | Cost of goods $58.2m (FY, 2025) | Cost of goods kr2.5m (FY, 2025) |
Gross profit | Gross profit $170.2m (FY, 2025) | Gross profit kr72m (FY, 2025) |

Oncopeptides is a clinical development pharmaceutical company.
View company